Budesonide reduced symptoms compared with placebo during Study days 5-10, but these changes failed to reach statistical significance (paired analysis involving both treatment periods, data not shown).
← all excerpts
Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis.
1
—
—